Predictors of diagnostic yield and surgical safety in stereotactic brain biopsy
Journal of Neuro-Oncology · 2026-05 · 177 (3)
DOI: 10.1007/s11060-026-05573-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuro-Oncology, online erschienen am 17.04.2026. Verfasst von Maged T Ghoche und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University of Pittsburgh School of Medicine, 200 Lothrop St, Pittsburgh, PA, 15213, USA. Hauptthemen laut MEDLINE: Stereotaxic Techniques, Brain Neoplasms, Brain. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Stereotactic brain biopsy (SBB) is a fundamental diagnostic procedure for intracranial lesions that are radiographically indeterminate or surgically inaccessible. While advances in navigation and perioperative care have enhanced safety, high-granularity data identifying independent predictors of diagnostic failure and complications in large longitudinal cohorts remain limited. METHODS: We retrospectively reviewed 725 adult patients (≥18 years) who underwent SBB at a tertiary academic center between 2014 and 2025. Primary outcomes included diagnostic yield and procedure-related complications, specifically postoperative hemorrhage. A 1:4 nearest-neighbor matched case-control design was used to assess predictors of non-diagnostic yield (n = 184) and postoperative hemorrhage (n = 95), controlling for age and temporal technological changes. Multivariate logistic regression was utilized to calculate odds ratios (OR) and 95% confidence intervals (CI). RESULTS: The overall diagnostic yield was 95.0% and the overall complication rate was 4.69%. Multivariate analysis revealed that low-yield pathology (e.g., low-grade glioma, inflammatory, or infectious lesions) was the sole independent predictor of a non-diagnostic result (OR 4.22, 95% CI 1.77–10.06, p = 0.001). Regarding surgical safety, deep-seated location was the only independent predictor of postoperative hemorrhage (OR 3.93, 95% CI 1.24–12.46, p = 0.019). Notably, no statistical differences in yield or safety were observed between robotic, frameless, and frame-based navigation platforms (p > 0.80). Median LOS was 1 day (mean 3.92 ± 5.23 days) and significantly declined over the study period (p = 0.023). Comparative analysis showed that LOS was identical between diagnostic and non-diagnostic groups. CONCLUSIONS: Over a decade of institutional experience, SBB demonstrated high diagnostic accuracy and safety across all navigation platforms. These findings identify lesion biology as the primary driver of non-diagnostic sampling and deep-seated location as the chief risk factor for hemorrhage. The comparable hospital resource utilization regardless of diagnostic outcome, combined with a declining LOS, supports the feasibility of standardized early-discharge pathways in modern neuro-oncology. CLINICAL TRIAL NUMBER: Not applicable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, University of Pittsburgh School of Medicine, 200 Lothrop St, Pittsburgh, PA, 15213, USA.
- Hillman Comprehensive Cancer Center, University of Pittsburgh Medical Center, 5115 Centre Ave, Pittsburgh, PA, 15232, USA.
- Department of Neurology, University of Pittsburgh School of Medicine, 200 Lothrop St, Pittsburgh, PA, 15213, USA.
- Department of Neurosurgery, University of Pittsburgh School of Medicine, 200 Lothrop St, Pittsburgh, PA, 15213, USA. abdullahkg@upmc.edu.
- Hillman Comprehensive Cancer Center, University of Pittsburgh Medical Center, 5115 Centre Ave, Pittsburgh, PA, 15232, USA. abdullahkg@upmc.edu.
- Department of Neurological Surgery, Hillman Cancer Center, University of Pittsburgh Medical Center, 5200 Centre Avenue, Suite 4B, Pittsburgh, PA, 15232, USA. abdullahkg@upmc.edu.
Zitieren
APA
Ghoche, M. T., Gecici, N. N., Miki, K., Yuan, F., Mantica, M., Zinn, P. O., & Abdullah, K. G. (2026). Predictors of diagnostic yield and surgical safety in stereotactic brain biopsy. Journal of Neuro-Oncology, 177(3). https://doi.org/10.1007/s11060-026-05573-9
Vancouver
Ghoche MT, Gecici NN, Miki K, Yuan F, Mantica M, Zinn PO, et al. Predictors of diagnostic yield and surgical safety in stereotactic brain biopsy. Journal of Neuro-Oncology. 2026;177(3). doi:10.1007/s11060-026-05573-9
BibTeX
@article{Ghoche2026,
author = {Ghoche, Maged T and Gecici, Neslihan Nisa and Miki, Kenji and Yuan, Fanen and Mantica, Megan and Zinn, Pascal O and Abdullah, Kalil G},
title = {Predictors of diagnostic yield and surgical safety in stereotactic brain biopsy},
journal = {Journal of Neuro-Oncology},
year = {2026},
volume = {177},
number = {3},
doi = {10.1007/s11060-026-05573-9}
}
EUVIMED